Skip to main content Skip to navigation Skip to accessibility tools
Cheshire and Merseyside Cancer Alliance Logo
National Health Service logo
  • Home
  • Work
    • Work
    • Prevention and Early Diagnosis
      • Prevention and Early Diagnosis
      • CURE Project - Smoking cessation in secondary care
        • CURE Project - Smoking cessation in secondary care
        • CURE Project - Smoking cessation in secondary care
        • Project 3
      • Making Every Contact Count (MECC)
      • Action on Cancer Toolkit
      • Strategic Overweight and Obesity Project
      • The PinPoint Test
      • Targeted Lung Health Checks
      • Early Diagnosis Community Engagement
    • Rapid Diagnostic Services
      • Rapid Diagnostic Services
      • RDS – Our Aims
        • RDS – Our Aims
        • Project 1
        • Project 2
        • Project 3
      • RDS programme - 2021/22 plan
        • RDS programme - 2021/22 plan
        • RDS Projects 2021/22
      • RDS – implementation support pack
    • Personalised care
      • Personalised care
      • What is personalised care?
        • What is personalised care?
        • Project 1
        • Project 2
        • Project 3
      • Personalised care interventions
        • Personalised care interventions
        • Quality of Life
        • Personalised Stratified Follow Up
        • Prehabilitation
      • Prostate Cancer - Personalised Stratified Follow-Up
    • Workforce
      • Workforce
      • Health and Wellbeing
    • Patient Experience and Health Inequalities
      • Patient Experience and Health Inequalities
      • Cancer Quality of Life Survey
      • National Cancer Patient Experience Survey
      • Under 16 Cancer Patient Experience Survey
      • Health Inequalities Library
    • Public engagement
    • Screening
    • Genomics
      • Genomics
      • North West Genomic Medicine Service Alliance
      • North West Genomics Laboratory Hub
  • Resources
    • Resources
    • PSFU Resources
      • PSFU Resources
      • Support and Documentation
    • Clinical Quality Groups
      • Clinical Quality Groups
      • Acute Oncology
      • Brain and Central Nervous System
      • Breast
      • Children
      • Colorectal
      • GP
      • Gynaecology
      • Head and Neck
      • Haematology
      • Lung
      • Oesophageal
      • Psychology
      • Sarcoma
      • Skin
      • Teenage and Young Adult
      • Urology
      • Genomics
    • Primary Care Resources
      • Primary Care Resources
      • Referral Practice
      • Improving local uptake of National Cancer Screening Programmes
      • Developing a Community of Practice with the Cancer Alliance
      • Tumour-specific advice for optimising 2ww referrals
      • Suspected Prostate Cancer Referrals
      • Patient Experience and Health Inequalities
    • Other Resources
      • Other Resources
      • Being Present - Remotely: Personalised Stratified Follow-Up in Cheshire and Merseyside during COVID-19
  • About
    • About
    • What is Cheshire & Merseyside Cancer Alliance?
    • Overview of cancer in Cheshire and Merseyside
    • Ambition and Achievements
    • Governance
    • Senior Management Team
    • Board Papers
    • Documents & Policies
    • Place plans
    • Work With Us
  • News
  • Public info
    • Public info
    • National Cancer Patient Experience Survey
    • Cancer Quality of Life Survey
    • Get Involved
    • Discuss Your Risk – Be Prostate Cancer Aware Campaign
  • Blogs

Haematology

  1. Home
  2. Resources
  3. Clinical Quality Groups
  4. Haematology
Back to Clinical Quality Groups

Chair - Jeffery Smith, Consultant Haematologist

Date of Next Meeting:

Thursday 20th October 2022

Current Trials Pathways - Updated February 2021

Patient Trial Pathways Leukaemia

Patient Trial Pathways Lymphoma

Patient Trial Pathways Myeloma

Patient Trial Pathways Stem Cell Transplantation and Cellular Therapy

Agreed Pathways and Guidelines - Updated October 2019

Acute Leukaemia

Autograft Haemopoietic Stem Cell Transplant Referral Proforma

BSBMT Indications Table Updated October 2019

Burkitt Lymphoma 2019 SIG

CAR T Application form ALL

CAR T Lymphoma Application Form

Cheshire & Merseyside Haematology MDT Structure

CLL 2019 SIG

CM Lymphoma June 2019

CML Pathway

Definitions for Disease Status and Response Lymphoma CLL

Definitions for Disease Status and Response - CLL

EBMT Response Criteria for Myeloma

Diffuse Large B Cell Lymphoma SIG

Disease Status at SCT - Lymphoma

Gastric MALToma 2019 SIG

Hairy Cell Leukaemia

Lymphoma June 2019

Referral into Acute Leukaemia Service

MPN June 2019

MDS Pathway July 2019

Myelofibrosis Pathway

Myeloma Pathway June 2019

Patient Transplant Referral Pathway

Agreed Pathways and Guidelines - Updated February 2020

Hodgkins Lympoma III IV SIGv2

Hogkins Lymphoma less Fit SIG

Mantle Cell Lymphoma SIG

Our long term ambition is to take every opportunity to prevent cancer and ensure outstanding cancer care is provided across Cheshire and Merseyside.

Contact us at: ccf-tr.admin.cmca@nhs.net

Graphic of a microscope
  • Sitemap
  • Website Privacy
  • Privacy Notice
  • Accessibility
  • Publication Scheme
  • Facebook Policy

Accessibility tools

Text size:
Contrast:
Frank Ltd.
Return to header